A detailed history of Ameriprise Financial Inc transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 134,852 shares of PSTX stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,852
Previous 131,502 2.55%
Holding current value
$1.27 Million
Previous $383,000 0.52%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.7 - $4.04 $9,045 - $13,534
3,350 Added 2.55%
134,852 $385,000
Q1 2024

May 15, 2024

BUY
$2.76 - $4.13 $259,406 - $388,170
93,988 Added 250.54%
131,502 $419,000
Q4 2023

Feb 14, 2024

BUY
$1.83 - $3.51 $68,650 - $131,674
37,514 New
37,514 $126,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $810M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.